Bausch Health Companies Quarterly Income Statement
NYSE: BHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch Health Companies revenue and earnings
In the quarter ended Jun 30, 2026, Bausch Health Companies generated $2.85 billion in revenue, up 12.7% from the same quarter a year earlier. Net income was $258.0 million (+74.3% year over year), for a net margin of 9.0% versus a median of -2.6% in the prior 5 quarters. Operating margin was 25.9%.
Diluted earnings per share came in at $0.68, up from $0.40.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch Health Companies income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.85B | 2.52B | 2.80B | 2.68B | 2.53B | 2.26B | 2.56B | 2.51B | 2.40B | 2.15B | 2.41B | 2.24B |
| Revenue growth (YoY) | +12.73% | +11.73% | +9.26% | +6.81% | +5.29% | +4.92% | +6.27% | +12.15% | +10.89% | +10.75% | +9.80% | +9.38% |
| Research & Development | 173.00M | 163.00M | 161.00M | 166.00M | 159.00M | 143.00M | 163.00M | 146.00M | 156.00M | 151.00M | 152.00M | 153.00M |
| Selling, General & Admin | 907.00M | 861.00M | 882.00M | 795.00M | 894.00M | 867.00M | 820.00M | 850.00M | 832.00M | 794.00M | 766.00M | 715.00M |
| Operating Income | 740.00M | -950.00M | 474.00M | 619.00M | 444.00M | 276.00M | 558.00M | 318.00M | 389.00M | 281.00M | 362.00M | 14.00M |
| Interest Expense | 396.00M | 402.00M | 397.00M | 412.00M | 465.00M | 330.00M | 337.00M | 346.00M | 350.00M | 355.00M | 363.00M | 339.00M |
| Other Income (Expense) | — | — | — | — | — | — | -2.00M | -225.00M | -20.00M | 0 | -28.00M | -60.00M |
| Pretax Income | 348.00M | -1.35B | 56.00M | 218.00M | 140.00M | -47.00M | 209.00M | -21.00M | 48.00M | -69.00M | -7.00M | -326.00M |
| Income Tax | 88.00M | 77.00M | 159.00M | 37.00M | 12.00M | 39.00M | 111.00M | 71.00M | 49.00M | 8.00M | 40.00M | 56.00M |
| Net Income | 258.00M | -1.42B | -112.00M | 179.00M | 148.00M | -58.00M | 93.00M | -85.00M | 10.00M | -64.00M | -39.00M | -378.00M |
| Net Income growth (YoY) | +74.32% | — | -220.43% | — | +1380.00% | — | — | — | -61.54% | — | — | -194.74% |
| EPS (Basic) | 0.69 | -3.82 | -0.30 | 0.48 | 0.40 | -0.16 | 0.24 | -0.23 | 0.03 | -0.17 | -0.11 | -1.03 |
| EPS (Diluted) | 0.68 | -3.82 | -0.30 | 0.48 | 0.40 | -0.16 | 0.24 | -0.23 | 0.03 | -0.17 | -0.11 | -1.03 |
| Shares Outstanding (Basic) | 375.00M | 372.80M | — | 371.30M | 370.90M | 369.60M | — | 368.40M | 367.90M | 366.80M | — | 365.40M |
| Shares Outstanding (Diluted) | 378.10M | 372.80M | — | 375.50M | 373.10M | 369.60M | — | 368.40M | 370.20M | 366.80M | — | 365.40M |
| EBITDA | 1.02B | -655.00M | 764.00M | 925.00M | 751.00M | 581.00M | 865.00M | 640.00M | 707.00M | 601.00M | 691.00M | 315.00M |
| Operating Margin | 25.95% | -37.64% | 16.95% | 23.09% | 17.55% | 12.22% | 21.81% | 12.67% | 16.19% | 13.05% | 15.03% | 63.00% |
| Net Margin | 9.05% | -56.38% | -4.01% | 6.68% | 5.85% | -2.57% | 3.63% | -3.39% | 42.00% | -2.97% | -1.62% | -16.89% |
This table shows 12 quarterly periods of Bausch Health Companies's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow BHC's reporting calendar. What is a income statement?